| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.42 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.05 |